Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Breast Cancer

Promising antitumor agents found to be effective in reducing effects of estrogen

According to a study from the United States, "Blocking estrogen receptors with antiestrogens and blocking estrogen synthesis with aromatase inhibitors are two strategies currently being used for reducing the effect of estrogen in postmenopausal estrogen receptor-positive breast cancer patients."

D. Jelovac and colleagues at the University of Maryland wrote, "To optimize these treatment strategies, [we] investigated whether tumor progression can be delayed by combining the pure antiestrogen fulvestrant with the nonsteroidal aromatase inhibitor letrozole."

...

• View Other Issues of Women's Health Weekly
  
• View Other NewsRx Publications